Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
September 17, 2026
Robigo and Leaps by Bayer Announce Series A Financing to Advance Engineered Biologicals That Protect Yields and Reduce Costs
September 17, 2026
Not intended for U.S. and UK Media
U.S. FDA approves finerenone for new indication in patients with chronic kidney disease associated with type 1 diabetes
September 09, 2026
Not intended for U.S. and UK Media
U.S. FDA grants accelerated approval to Bayer’s targeted therapy sevabertinib as a first-line treatment option for adults with HER2-mutant non-small cell lung cancer
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
